세계의 인간 유전자 시퀀싱 시장 : 전략과 동향 - 용도별, 기술별, 워크플로우별, 제품별, 국가별 예측 - 경영진 컨설턴트 가이드와 인공지능(AI)의 영향(2025-2029년)

Human Gene Sequencing Markets, Strategies & Trends. Forecasts by Application, by Technology, by Workflow, by Product, and by Country. With Executive and Consultant Guides and Impact of Artificial Intelligence. 2025 to 2029

US $ 6,995 ￦ 9,633,000

PDF (Single User License)

PDF 보고서를 1명(One device)만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,495 ￦ 14,453,000

PDF (Five User License)

PDF 보고서를 동일 사업장의 5명(Five devices)까지 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 13,995 ￦ 19,273,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

모든 신생아가 출생 시 유전자 검사를 받게 될까요? 급성장하고 있는 분야는 무엇이며, 시퀀싱이 주류가 된 지금, 기회는 어디에 있을까요?

유전체 시퀀싱 비용이 급락하면서 골드러시가 일어나고 있습니다. 새로운 소비자, 새로운 기술, 새로운 시장 틈새가 등장하여 인터넷 산업의 탄생을 연상시킵니다. 자금력을 갖춘 다양한 진출기업들이 세계 무대에서 시장 점유율을 놓고 경쟁하고 있습니다. 본 보고서는 5년 후 시장 규모를 예측하고, 14개 국가와 5개 지역에 대한 상세한 분석을 담고 있습니다.

종양세포 시퀀싱, D2C, 유전자 발현 등 전문용어를 알기 쉽게 설명합니다. 또한, 과제와 기회, 함정에 대해 살펴보고 향후 5년간의 성장 전망과 최종 시장 예측을 이해할 수 있습니다.

모든 보고서 데이터는 요청에 따라 엑셀 형식으로 제공될 수 있습니다.

세계의 인간 유전자 시퀀싱(Human Gene Sequencing) 시장에 대해 조사했으며, 시장 개요와 함께 용도별/기술별/워크플로우별/제품별/국가별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 시장 가이드

제2장 서론과 시장의 정의

• 이 보고서의 유전자 배열 정의
• 유전체학 혁명
• 시장 정의
• 조사 방법
• 시점 : 헬스케어와 IVD 업계
• 염색체, 유전자 및 에피제네틱스

제3장 세계의 시퀸서 설치 기반 리스트 - 소재지와 연락처

제4장 시장 개요

• 시장 참여 조직
  • 학술연구기관
  • 진단 시험 개발자
  • 계측 기기 공급업체
  • 약품 및 시약 제조업체
  • 병리 공급업체
  • 독립계 임상 실험실
  • 공공 국립 및 지역 연구소
  • 병원 검사실
  • 임상 실험실
  • 감사기관
  • 인증기관
• 인간 유전자 배열 분석-시장, 사례, 인사이트
• 업계 구조

제5장 시장 동향

• 성장 촉진요인
• 성장 억제요인
• 시퀀싱 기기

제6장 인간 유전자 배열 분석의 최근 동향

제7장 주요 기업 개요

• 10x Genomics, Inc.
• 23andME Inc.
• Abbott Laboratories
• AccuraGen Inc.
• Adaptive Biotechnologies
• Admera Health, LLC
• Advanced Biological Laboratories
• Agilent
• Akonni Biosystems
• Amoy Diagnostics Co., Ltd.
• Ancestry.com LLC
• Anchor Dx
• Arrayit Corporation
• ARUP Laboratories
• Astrid Bio
• Azenta
• BaseClear
• Baylor Miraca Genetics Laboratories
• Beckman Coulter Diagnostics(Danaher)
• Becton, Dickinson and Company
• BGI Genomics Co. Ltd
• Bioarray Genetics
• BioBam
• Biocept, Inc.
• Biodesix Inc.
• BioFluidica
• BioGenex
• Biolidics Ltd
• bioMerieux Diagnostics
• Bioneer Corporation
• Bio-Rad Laboratories, Inc.
• Bio-Techne
• Burning Rock
• C2i Genomics
• Cantata Bio
• CareDx
• Caris Molecular Diagnostics
• Celemics
• CellMax Life
• Centogene
• Cepheid(Danaher)
• Circulogene
• Clearbridge Biomedics
• Clinical Genomics
• Color Genomics
• Complete Genomics(MGI Tech)
• CosmosID
• Dante Labs
• Datar Cancer Genetics Limited
• Diasorin S.p.A.
• Easy DNA
• Element Biosciences
• Epic Sciences
• Epigenomics AG
• Eurofins Scientific
• Excellerate Bioscience
• Fabric Genomics
• Freenome
• FUJIFILM Wako Diagnostics
• Fujirebio
• Fulgent Genetics
• GE Global Research
• Gene by Gene, Ltd.
• Genedrive
• GeneDx Holdings
• GeneFirst Ltd.
• GeneFluidics
• Genetron Holdings
• Genewiz
• Genomics England
• Genomics Personalized Health(GPH)
• GenomOncology
• Genzyme Corporation
• Grifols
• Guardant Health
• Guardiome
• Helix
• Hologic
• HTG Molecular Diagnostics
• Human Longevity, Inc.
• iCellate
• Illumina
• Incell Dx
• Inivata
• Invitae Corporation
• Invivoscribe
• Karius
• Letsgetchecked
• Lucence Health
• Lunglife AI Inc
• Macrogen
• MDNA Life SCIENCES, Inc.
• MDx Health
• Medgenome
• Meridian Bioscience
• Mesa Laboratories, Inc.
• Metabiomics Corp
• miR Scientific
• NantHealth, Inc.
• Natera
• Nebula Genomics
• NeoGenomics
• New England Biolabs, Inc.
• NGeneBio
• Norgen Biotek Corp.
• Novogene
• Omega Bioservices
• Oncocyte
• OncoDNA
• OpGen
• Origene Technologies
• Oxford Nanopore Technologies
• Pacific Biosciences
• Panagene
• PathoQuest S.A.
• Personalis
• PGDx(Labcorp)
• Precipio
• PrecisionMed
• Predictive Oncology
• Promega
• Qiagen
• QuantuMDx
• Regeneron Pharmaceuticals
• Revvity
• Roche Diagnostics
• Roswell Biotechnologies
• Seegene
• SeLux Diagnostics
• Sequencing.com
• Siemens Healthineers
• simfo GmbH
• Singlera Genomics Inc.
• Singular Genomics
• SkylineDx
• Standard BioTools
• Sysmex
• Sysmex Inostics
• Tempus Labs, Inc.
• Thermo Fisher Scientific
• Ultima Genomics
• Unchained Labs
• Variantyx
• Vela Diagnostics
• VolitionRX
• Zymo Research Corp

제8장 세계의 인간 유전자 시퀀싱 시장

• 국가별 세계 시장 개요
• 용도별 세계 시장 - 개요
• 기술별 세계 시장 - 개요
• 워크플로우별 세계 시장 - 개요
• 제품별 세계 시장 - 개요

제9장 용도별 시장 규모

• 유전성 유전자 시퀀싱
• NIPT 유전자 시퀀싱
• 종양학
• 심리학
• WGES 유전자 시퀀싱
• 약물유전체학
• DTC 유전자 시퀀싱
• 연구용 유전자 시퀀싱
• 기타

제10장 기술별 시장 규모

• 생어 염기서열 분석
• NGS/2G
• 3G/Long
• 기타

제11장 워크플로우별 시장 규모

• 시퀀싱
• 샘플 조제
• 분석

제12장 제품별 시장 규모

• 기기
• 소모품
• 소프트웨어 및 서비스

제13장 인간 유전자 시퀀싱의 향후 비전

제14장 부록

LSH

영문 목차

영문목차

OVERVIEW:

Will all newborns receive genetic testing at birth? What segments are growing fastest? Where are the opportunities now that sequencing has gone mainstream?

Our facts and support = Your success.

The plummeting costs for Genome Sequencing is creating a gold rush. New consumers, new technologies, new market niches. It is reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out for five years. The report includes detailed breakouts for 14 countries and 5 regions.

Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities, and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

All report data is available in Excel format on request.

Table of Contents

1. Market Guides

• 1.1. Human Gene Sequencing Markets - Strategic Situation Analysis
• 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
• 1.3. Guide for Management Consultants and Investment Advisors
• 1.4. Impact of Artificial Intelligence on Gene Sequencing Market

2. Introduction and Market Definition

• 2.1. Gene Sequencing Definition In This Report
  • 2.1.1. Gene Sequencing
  • 2.1.2. Hereditary
  • 2.1.3. Non Invasive Prenatal Testing
  • 2.1.4. Oncology
  • 2.1.5. Psychology
  • 2.1.6. WGES
  • 2.1.7. Pharmacogenomic
  • 2.1.8. Direct to Consumer
  • 2.1.9. Research
  • 2.1.10. Other
• 2.2. The Genomics Revolution
• 2.3. Market Definition
  • 2.3.1. Revenue Market Size
• 2.4. Methodology
  • 2.4.1. Methodology
  • 2.4.2. Sources
  • 2.4.3. Authors
• 2.5. Perspective: Healthcare and the IVD Industry
  • 2.5.1. Global Healthcare Spending
  • 2.5.2. Spending on Diagnostics
  • 2.5.3. Important Role of Insurance for Diagnostics
• 2.6. Chromosomes, Genes and Epigenetics
  • 2.6.1. Chromosomes
  • 2.6.2. Genes
  • 2.6.3. Epigenetics
  • 2.6.4. Genetic Testing vs. Gene Sequencing
  • 2.6.5. Cost and Pricing Practice

3. Global Listing of Sequencer Installed Base - Location & Contacts

• 3.1. Notes to Installed Base Listing
• 3.2. Illumina Installed Base

4. Market Overview

• 4.1. Players in a Dynamic Market
  • 4.1.1. Academic Research Lab
  • 4.1.2. Diagnostic Test Developer
  • 4.1.3. Instrumentation Supplier
  • 4.1.4. Chemical/Reagent Supplier
  • 4.1.5. Pathology Supplier
  • 4.1.6. Independent Clinical Laboratory
  • 4.1.7. Public National/regional Laboratory
  • 4.1.8. Hospital Laboratory
  • 4.1.9. Physicians Office Lab (POLS)
  • 4.1.10. Audit Body
  • 4.1.11. Certification Body
• 4.2. Human Gene Sequencing -Markets, Examples and Discussion
  • 4.2.1. Inherited Disease - Not what it used to be
    • 4.2.1.1. Clinical and Research Lines Blur
    • 4.2.1.2. Genetic Counselling - Not so simple anymore
    • 4.2.1.3. The Genetic Blizzard - Issues of Access and Payment
  • 4.2.2. Newborn Screening - The Standard of Care
    • 4.2.2.1. Newborn Screening - Do Parents Want to Know?
  • 4.2.3. NIPT - We've Only Just Begun
    • 4.2.3.1. NIPT, IVF and the Fertility Practice - PGS, PGD, CCS
    • 4.2.3.2. NIPT in the Future - Beyond Inherited Disease
  • 4.2.4. Oncology - Understanding Two Worlds
    • 4.2.4.1. The Tumor - A Sequence of Sequencing
    • 4.2.4.2. The Tumor - Biopsy and Liquid Biopsy
    • 4.2.4.3. The Human Genome - Predisposition and Prognosis
  • 4.2.5. Pharmacogenomics
    • 4.2.5.1. Sequencing Not the Only Player
    • 4.2.5.2. New Roles for Old Drugs - A Research Bonanza?
  • 4.2.6. Direct To Consumer - More Than Meets the Eye
    • 4.2.6.1. DTC - How Many Segments?
• 4.3. Industry Structure
  • 4.3.1. Hospital's Testing Share
  • 4.3.2. The Rise of the Sequencing Lab
  • 4.3.3. Sequencing as a Commodity
  • 4.3.4. Informatics
  • 4.3.5. Instrument Manufacturer Role
  • 4.3.6. Healthcare Industry Impacts - Still Struggling
  • 4.3.7. Can the Healthcare Industry Adapt?
  • 4.3.8. Genetic Counselling as an Industry
  • 4.3.9. Sequencing Adoption and Cannibalization

5. Market Trends

• 5.1. Factors Driving Growth
  • 5.1.1. New Diagnoses
  • 5.1.2. Wellness and Prevention
  • 5.1.3. Fertility Technology
  • 5.1.4. Cancer - Screening, Management and Monitoring
• 5.2. Factors Limiting Growth
  • 5.2.1. Increased Competition Lowers Price
  • 5.2.2. Lower Costs
  • 5.2.3. Healthcare Cost Concerns Curtail Growth
  • 5.2.4. Wellness has a downside
• 5.3. Sequencing Instrumentation
  • 5.3.1. Instrumentation Tenacity
  • 5.3.2. Declining Cost of Instruments Changes Industry Structure
  • 5.3.3. Long Reads - Further Segmentation
  • 5.3.4. Linked Reads
  • 5.3.5. New Sequencing Technologies

6. Human Gene Sequencing Recent Developments

• 6.1. Recent Developments - Importance and How to Use This Section
  • 6.1.1. Importance of These Developments
  • 6.1.2. How to Use This Section
• 6.2. Adaptive Biotechnologies MRD Testing Grows
• 6.3. GeneDx to Acquire Fabric Genomics
• 6.4. Inclusive Newborn Sequencing Shows Potential
• 6.5. Delve Bio: Delve Detect
• 6.6. Caris CDx Assay Approval
• 6.7. Ambry Genetics: ExomeReveal
• 6.8. WGS Improves Pediatric Cancer Care
• 6.9. Cancer genomes identify candidate driver genes
• 6.10. Genetic Dx a game changer
• 6.11. Nonacus Galeas Tumor
• 6.12. Lucence LiquidHallmark Assay Gets Coverage
• 6.13. Garvan Institute Gets Gramt to Develop Genomics Tests
• 6.14. Arima Genomics, Protean BioDiagnostics Launch Joint Venture
• 6.15. Geneseeq Nabs CE Marks for Cancer Test Kits
• 6.16. Viome Life Sciences Announces Gut Intelligence Test
• 6.17. Quest Diagnostics Announces Genetic Insights
• 6.18. Exact Sciences Releases Next-Gen Cologuard
• 6.19. BGI Genomics Forges Partnerships in Latin America
• 6.20. 4bases Bets on NGS Diagnostics
• 6.21. Guardant Health Submits Colorectal Cancer Screening Test
• 6.22. Universal DX Eyeing Approval for Colorectal Cancer Screening Test
• 6.23. Natera Files Suit Against NeoGenomics
• 6.24. Genomics England to Sequence 100K Newborns
• 6.25. Novigenix Raises $14M for NGS based Liquid Biopsy
• 6.26. LetsGetChecked Launching New PGx Service
• 6.27. Qiagen, Neuron23 Partner for NGS Diagnostic
• 6.28. Harbinger Health Technology Focused On Oncogenesis
• 6.29. Delfi Diagnostics to Develop Early Detection Test
• 6.30. Dante Labs to Introduce WGS to Italian Healthcare System
• 6.31. Invitae Neurodevelopmental Disorders Testing Service
• 6.32. Thermo Fisher Obtains CE Mark for Ion Torrent Genexus
• 6.33. Myriad Genetics Launches Suite of Cancer Tests
• 6.34. Oncocyte and Thermo Fisher Strike Partnership Deal
• 6.35. Illumina Partners With Precision Medicine to Assess Liquid Biopsy
• 6.36. Sysmex Inostics Develops Ultra-Sensitive Liquid Biopsy
• 6.37. Twist Bioscience, Centogene Partner on NGS-Based Rare Disease Testing
• 6.38. Strata Oncology Trial Supports NGS Assay
• 6.39. NYU Gets FDA Clearance for Sequencing Test
• 6.40. NeoGenomics to Acquire Inivata
• 6.41. OncoDNA, Institut Curie Partner on Liquid Biopsy Research
• 6.42. Cancer Heritability Gene Set Expanded
• 6.43. Whole-Genome Sequencing Could Replace Cytogenetics
• 6.44. Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays
• 6.45. Ancestry Shutters Health Offering
• 6.46. Genetron Health Targeting Early Cancer Detection
• 6.47. Pan-European Initiative to Build Tools for Sharing Genomic Data
• 6.48. UK Government Unveils New Genomic Healthcare Strategy
• 6.49. Foundation Medicine Liquid Biopsy Gets FDA Approval
• 6.50. American Heart Association Develops Genetic Testing Guidelines
• 6.51. Yourgene Health Gets CE Mark for Iona NIPT Test
• 6.52. NorthShore Looks to Expand Genomics Integration Into Primary Care
• 6.53. Germline Results From Tumor Sequencing Guides Precision Therapy
• 6.54. FDA Clears Cancer Genomic Profiling From Personal Genome Diagnostics
• 6.55. BillionToOne Closes $15M Series A Follow-on Round
• 6.56. Clinics to Integrate Genomics Into Primary Care

7. Profiles of Key Companies

• 7.1. 10x Genomics, Inc.
• 7.2. 23andME Inc.
• 7.3. Abbott Laboratories
• 7.4. AccuraGen Inc.
• 7.5. Adaptive Biotechnologies
• 7.6. Admera Health, LLC
• 7.7. Advanced Biological Laboratories
• 7.8. Agilent
• 7.9. Akonni Biosystems
• 7.10. Amoy Diagnostics Co., Ltd.
• 7.11. Ancestry.com LLC
• 7.12. Anchor Dx
• 7.13. Arrayit Corporation
• 7.14. ARUP Laboratories
• 7.15. Astrid Bio
• 7.16. Azenta
• 7.17. BaseClear
• 7.18. Baylor Miraca Genetics Laboratories
• 7.19. Beckman Coulter Diagnostics (Danaher)
• 7.20. Becton, Dickinson and Company
• 7.21. BGI Genomics Co. Ltd
• 7.22. Bioarray Genetics
• 7.23. BioBam
• 7.24. Biocept, Inc.
• 7.25. Biodesix Inc.
• 7.26. BioFluidica
• 7.27. BioGenex
• 7.28. Biolidics Ltd
• 7.29. bioMerieux Diagnostics
• 7.30. Bioneer Corporation
• 7.31. Bio-Rad Laboratories, Inc.
• 7.32. Bio-Techne
• 7.33. Burning Rock
• 7.34. C2i Genomics
• 7.35. Cantata Bio
• 7.36. CareDx
• 7.37. Caris Molecular Diagnostics
• 7.38. Celemics
• 7.39. CellMax Life
• 7.40. Centogene
• 7.41. Cepheid (Danaher)
• 7.42. Circulogene
• 7.43. Clearbridge Biomedics
• 7.44. Clinical Genomics
• 7.45. Color Genomics
• 7.46. Complete Genomics (MGI Tech)
• 7.47. CosmosID
• 7.48. Dante Labs
• 7.49. Datar Cancer Genetics Limited
• 7.50. Diasorin S.p.A.
• 7.51. Easy DNA
• 7.52. Element Biosciences
• 7.53. Epic Sciences
• 7.54. Epigenomics AG
• 7.55. Eurofins Scientific
• 7.56. Excellerate Bioscience
• 7.57. Fabric Genomics
• 7.58. Freenome
• 7.59. FUJIFILM Wako Diagnostics
• 7.60. Fujirebio
• 7.61. Fulgent Genetics
• 7.62. GE Global Research
• 7.63. Gene by Gene, Ltd.
• 7.64. Genedrive
• 7.65. GeneDx Holdings
• 7.66. GeneFirst Ltd.
• 7.67. GeneFluidics
• 7.68. Genetron Holdings
• 7.69. Genewiz
• 7.70. Genomics England
• 7.71. Genomics Personalized Health (GPH)
• 7.72. GenomOncology
• 7.73. Genzyme Corporation
• 7.74. Grifols
• 7.75. Guardant Health
• 7.76. Guardiome
• 7.77. Helix
• 7.78. Hologic
• 7.79. HTG Molecular Diagnostics
• 7.80. Human Longevity, Inc.
• 7.81. iCellate
• 7.82. Illumina
• 7.83. Incell Dx
• 7.84. Inivata
• 7.85. Invitae Corporation
• 7.86. Invivoscribe
• 7.87. Karius
• 7.88. Letsgetchecked
• 7.89. Lucence Health
• 7.90. Lunglife AI Inc
• 7.91. Macrogen
• 7.92. MDNA Life SCIENCES, Inc.
• 7.93. MDx Health
• 7.94. Medgenome
• 7.95. Meridian Bioscience
• 7.96. Mesa Laboratories, Inc.
• 7.97. Metabiomics Corp
• 7.98. miR Scientific
• 7.99. NantHealth, Inc.
• 7.100. Natera
• 7.101. Nebula Genomics
• 7.102. NeoGenomics
• 7.103. New England Biolabs, Inc.
• 7.104. NGeneBio
• 7.105. Norgen Biotek Corp.
• 7.106. Novogene
• 7.107. Omega Bioservices
• 7.108. Oncocyte
• 7.109. OncoDNA
• 7.110. OpGen
• 7.111. Origene Technologies
• 7.112. Oxford Nanopore Technologies
• 7.113. Pacific Biosciences
• 7.114. Panagene
• 7.115. PathoQuest S.A.
• 7.116. Personalis
• 7.117. PGDx (Labcorp)
• 7.118. Precipio
• 7.119. PrecisionMed
• 7.120. Predictive Oncology
• 7.121. Promega
• 7.122. Qiagen
• 7.123. QuantuMDx
• 7.124. Regeneron Pharmaceuticals
• 7.125. Revvity
• 7.126. Roche Diagnostics
• 7.127. Roswell Biotechnologies
• 7.128. Seegene
• 7.129. SeLux Diagnostics
• 7.130. Sequencing.com
• 7.131. Siemens Healthineers
• 7.132. simfo GmbH
• 7.133. Singlera Genomics Inc.
• 7.134. Singular Genomics
• 7.135. SkylineDx
• 7.136. Standard BioTools
• 7.137. Sysmex
• 7.138. Sysmex Inostics
• 7.139. Tempus Labs, Inc.
• 7.140. Thermo Fisher Scientific
• 7.141. Ultima Genomics
• 7.142. Unchained Labs
• 7.143. Variantyx
• 7.144. Vela Diagnostics
• 7.145. VolitionRX
• 7.146. Zymo Research Corp

8. The Global Market for Human Genome Sequencing

• 8.1. Global Market Overview by Country
  • 8.1.1. Table - Global Market by Country
  • 8.1.2. Chart - Global Market by Country
• 8.2. Global Market by Application - Overview
  • 8.2.1. Table - Global Market by Application
  • 8.2.2. Chart - Global Market by Application - Base/Final Year Comparison
  • 8.2.3. Chart - Global Market by Application - Base Year
  • 8.2.4. Chart - Global Market by Application - Final Year
  • 8.2.5. Chart - Global Market by Application - Share by Year
  • 8.2.6. Chart - Global Market by Application - Segment Growth
• 8.3. Global Market by Technology - Overview
  • 8.3.1. Table - Global Market by Technology
  • 8.3.2. Chart - Global Market by Technology - Base/Final Year Comparison
  • 8.3.3. Chart - Global Market by Technology - Base Year
  • 8.3.4. Chart - Global Market by Technology - Final Year
  • 8.3.5. Chart - Global Market by Technology - Share by Year
  • 8.3.6. Chart - Global Market by Technology - Segment Growth
• 8.4. Global Market by Workflow - Overview
  • 8.4.1. Table - Global Market by Workflow
  • 8.4.2. Chart - Global Market by Workflow - Base/Final Year Comparison
  • 8.4.3. Chart - Global Market by Workflow - Base Year
  • 8.4.4. Chart - Global Market by Workflow - Final Year
  • 8.4.5. Chart - Global Market by Workflow - Share by Year
  • 8.4.6. Chart - Global Market by Workflow - Segment Growth
• 8.5. Global Market by Product - Overview
  • 8.5.1. Table - Global Market by Product
  • 8.5.2. Chart - Global Market by Product - Base/Final Year Comparison
  • 8.5.3. Chart - Global Market by Product - Base Year
  • 8.5.4. Chart - Global Market by Product - Final Year
  • 8.5.5. Chart - Global Market by Product - Share by Year
  • 8.5.6. Chart - Global Market by Product - Segment Growth

9. Market Sizes by Application

• 9.1. Hereditary Gene Sequencing Market
  • 9.1.1. Table - Hereditary by Country
  • 9.1.2. Chart - Hereditary Segment Growth
• 9.2. NIPT Gene Sequencing Market
  • 9.2.1. Table NIPT by Country
  • 9.2.2. Chart - NIPT Growth
• 9.3. Oncology Market
  • 9.3.1. Table - Oncology by Country
  • 9.3.2. Chart - Oncology Growth
• 9.4. Psychology Market
  • 9.4.1. Table - Psychology by Country
  • 9.4.2. Chart - Psychology Growth
• 9.5. WGES Gene Sequencing Market
  • 9.5.1. Table - WGES by Country
  • 9.5.2. Chart - WGES growth
• 9.6. Pharmacogenomics Market
  • 9.6.1. Table Pharmacogenomics by Country
  • 9.6.2. Chart - Pharmacogenomics Growth
• 9.7. DTC Gene Sequencing Market
  • 9.7.1. Table - DTC by Country
  • 9.7.2. Chart - DTC Growth
• 9.8. Research Gene Sequencing Market
  • 9.8.1. Table - Research by Country
  • 9.8.2. Chart - Research Growth
• 9.9. Other Application Market
  • 9.9.1. Table - Other Application by Country
  • 9.9.2. Chart - Other Application growth

10. Market Sizes by Technology

• 10.1. Sanger Sequencing Market
  • 10.1.1. Table - Sanger by Country
  • 10.1.2. Chart - Sanger Segment Growth
• 10.2. NGS/2G Market
  • 10.2.1. Table NGS/2G by Country
  • 10.2.2. Chart - NGS/2G Growth
• 10.3 3G/Long Market
  • 10.3.1. Table - 3G/Long by Country
  • 10.3.2. Chart - 3G/Long Growth
• 10.4. Other Technology Market
  • 10.4.1. Table - Other Technology by Country
  • 10.4.2. Chart - Other Technology Growth

11. Market Sizes by Workflow

• 11.1. Sequencing Market
  • 11.1.1. Table - Sequencing by Country
  • 11.1.2. Chart - Sequencing Segment Growth
• 11.2. Sample Prep Market
  • 11.2.1. Table Sample Prep by Country
  • 11.2.2. Chart - Sample Prep Growth
• 11.3. Analysis Market
  • 11.3.1. Table - Analysis by Country
  • 11.3.2. Chart - Analysis Growth

12. Market Sizes by Product

• 12.1. Instruments Market
  • 12.1.1. Table - Instruments by Country
  • 12.1.2. Chart - Instruments Segment Growth
• 12.2. Consumables Market
  • 12.2.1. Table Consumables by Country
  • 12.2.2. Chart - Consumables Growth
• 12.3. Software & Services Market
  • 12.3.1. Table - Software & Services by Country
  • 12.3.2. Chart - Software & Services Growth

13. Vision of the Future of Human Gene Sequencing

14. Appendices

• 14.1. Growth of Approved IVD Test Menu
• 14.2. Growth of Approved Average IVD Test Fee
• 14.3. The Most Used IVD Assays
• 14.4. The Highest Grossing Assays
• 14.5. Laboratory Fees Schedule
• 14.6. The Whole Genome Sequence of SARS-CoV-2

관련자료